|
Volumn 287, Issue 5, 2002, Pages 578-
|
From the Food and Drug Administration.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CONTRACEPTIVE AGENT;
DERMATOLOGICAL AGENT;
DRUG DERIVATIVE;
ETHINYLESTRADIOL;
ISOTRETINOIN;
LEVONORGESTREL;
ADULT;
ARTICLE;
CHILD;
FEMALE;
FOOD AND DRUG ADMINISTRATION;
HEART SEPTUM DEFECT;
HUMAN;
INTRADERMAL DRUG ADMINISTRATION;
MALE;
PROSTHESES AND ORTHOSES;
RISK MANAGEMENT;
UNITED STATES;
ADMINISTRATION, CUTANEOUS;
ADULT;
CHILD;
CONTRACEPTIVE AGENTS, FEMALE;
DERMATOLOGIC AGENTS;
ETHINYL ESTRADIOL;
FEMALE;
HEART SEPTAL DEFECTS, ATRIAL;
HEART SEPTAL DEFECTS, VENTRICULAR;
HUMANS;
ISOTRETINOIN;
LEVONORGESTREL;
MALE;
PROSTHESES AND IMPLANTS;
RISK MANAGEMENT;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
MLCS;
MLOWN;
|
EID: 0037028787
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.287.5.578-jfd20002-3-1 Document Type: Article |
Times cited : (9)
|
References (0)
|